EIF2AK1 Antikörper (C-Term)
Kurzübersicht für EIF2AK1 Antikörper (C-Term) (ABIN7838061)
Target
Alle EIF2AK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Rabbit polyclonal antibody to EIF2AK1
-
Spezifität
- Recognizes endogenous levels of EIF2AK1 protein.
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human EIF2AK1. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000), IH (1/50 - 1/100)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- EIF2AK1 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (EIF2AK1))
-
Andere Bezeichnung
- EIF2AK1
-
Hintergrund
- HRI, KIAA1369, Eukaryotic translation initiation factor 2-alpha kinase 1, Heme-controlled repressor, HCR, Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase, Heme-regulated inhibitor, Hemin-sensitive initiation factor 2-alpha kinase
-
Gen-ID
- 27102, 15467, 27137
-
UniProt
- Q9BQI3
-
Pathways
- Hepatitis C
Target
-